LuisT.CamposMD

PubMed

• 47 citations
  A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellul...
  Devalingam Mahalingam, Julio Peguero, Putao Cen, Sukeshi Patel Arora, John Sarantopoulos, Julie Rowe, Victoria Allgood, Benjamin Tubb, Luis T. Campos> ;Cancers. 2019 Jun 17
• 32 citations
  A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic ...
  Lee S. Schwartzberg, Francis P. Arena, Bryan J. Bienvenu, Edward H. Kaplan, Luis H. Camacho, Luis T. Campos, J. Paul Waymack, Mary Tagliaferri, Michael M. Chen, Dapeng Li> ;Journal of Cancer. 2017 Jul 3
• 8 citations
  Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer
  John Sarantopoulos, Monica M. Mita, Michael J. Birrer, Lee D. Cranmer, Luis T. Campos, Xiaoping Zhang, Penelope Bristow, Hidekuni Kaito, Vincent Strout, Luis H. Camacho> ;Targeted Oncology. 2016 Jun 1
• 1 citations
  Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors
  Anthony J. Olszanski, David Smith, Luis H. Camacho, John A. Thompson, Suresh S. Ramalingam, R. Donald Harvey, Luis T. Campos, David Ferry, Shande Tang, Ling Gao, Howar...> ;The Oncologist. 2016 Apr 1
• 1175 citations
  Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063):...
  Naiyer A. Rizvi, Julien Mazieres, David Planchard, Thomas E. Stinchcombe, Grace K. Dy, Scott J. Antonia, Leora Horn, Hervé Lena, Elisa Minenza, Bertrand Mennecier, Gre...> ;The Lancet. Oncology. 2015 Mar 1
• 81 citations
  Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer
  Johanna C. Bendell, John Nemunaitis, Sasha Vukelja, Christopher Hagenstad, Luis T. Campos, Robert C. Hermann, Peter Sportelli, L. Gardner, Donald A. Richards> ;Journal of Clinical Oncology. 2011 Nov 20
• Phase II study of single agent perifosine in patients with hepatocellular carcinoma (HCC).
  Campos LT, Nemunaitis J, Stephenson J, Richards D, Barve M, Gardner L, Niecestro R, Sportelli P> ;J. Clin. Oncol.. 2009-05-20
• Randomized phase II study of perifosine in combination with capecitabine versus capecitabine alone in patients with second- or third-line metastatic colon cancer.
  Vukelja S, Richards D, Campos LT, Bedell C, Hagenstad C, Hyman W, Letzer J, Gardner L, Sportelli P, Nemunaitis J> ;J. Clin. Oncol.. 2009-05-20
• Phase I multicenter trial of perifosine in combination with sorafenib for patients with advanced cancers including renal cell carcinoma.
  Schreeder MT, Figlin RA, Stephenson JJ, Campos L, Chawla SP, Spigel DR, Spira A, Sportelli P, Gardner L, Birch R, Henderson IC> ;J. Clin. Oncol.. 2008-05-20
• 93 citations
  Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in com...
  Vicki A. Morrison, Mitchell D. Wong, Dawn L. Hershman, Luis T. Campos, Beiying Ding, Jennifer Malin> ;Journal of Managed Care Pharmacy. 2007 May 1
• Frequency of neutropenia-related events during chemotherapy and the use of pegfilgrastim and filgrastim in community practice: Results of the ACCEPT study.
  Campos LT, Folbe M, Meza L, Charu V, Dansey R, Xie F> ;J. Clin. Oncol.. 2005-06-01
• Pegfilgrastim and filgrastim patterns of use in community oncology practices: Results of the ACCEPT study.
  Meza LA, Charu V, Campos L, Davis D, Xie F> ;J. Clin. Oncol.. 2005-06-01
• Near-tetraploid acute myeloid leukemias: An EGIL retrospective study of 29 cases.
  Lemez P, Bene M, Campos L, Castoldi G, Derolf A, Garand R, Haas T, Haferlach T> ;J. Clin. Oncol.. 2005-06-01
• 3 citations
  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
  Luis T. Campos> ;Cancer. 1993 Feb 1
• 116 citations
  Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
  Richard Pazdur, Jaffer A. Ajani, Y Z Patt, Rodger J. Winn, D Jackson, B Shepard, R DuBrow, L Campos, M Quaraishi, J Faintuch> ;Journal of Clinical Oncology. 1990 Dec 1
• 58 citations
  Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens.
  Aman U Buzdar, Sewa S. Legha, Gabriel N. Hortobagyi, Hwee-Yong Yap, Charles L. Wiseman, Alfred Distefano, Frank C. Schell, Brian C. Barnes, Luis T. Campos, George R. B...> ;Cancer. 1981 Jun 15
• 39 citations
  Postoperative Adjuvant Chemotherapy With Fluorouracil, Doxorubicin, Cyclophosphamide, and BCG Vaccine: A Follow-up Report
  Aman U. Buzdar, George R. Blumenschein, Jordan U. Gutterman, Charles K. Tashima, Gabriel N. Hortobagyi, Terry L. Smith, Luis T. Campos, Warren L. Wheeler, Edmund A. Ge...> ;JAMA. 1979 Oct 5
• Join now to see all